Posted inBiotechnology
Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers
The beleaguered genomic medicine biotech Sangamo has traveled a rough road lately, with recent years featuring dashed R&D dreams and a…








